| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $215.1M | +15.1% | +12.4% |
| Cost of Revenue | $15.3M | -7.8% | -13.6% |
| R&D Expense | $15.7M | -12.3% | -31.7% |
| SG&A Expense | $14.4M | +5.1% | -9.4% |
| Operating Income | $34.4M | +221.5% | +421.2% |
| Pre-tax Income | $35.5M | +208.7% | +355.1% |
| Income Tax | $9.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $120.6M | +14.5% | +68.2% |
| Accounts Receivable | $121.9M | +24.6% | +18.6% |
| Current Assets | $275.1M | +15.2% | +42.0% |
| Total Assets | $492.8M | +3.5% | +22.5% |
| Current Liabilities | $74.4M | +7.4% | +11.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $92.7M | — | — |
| Capital Expenditures | $1.0M | — | — |
| Investing Cash Flow | -$20.4M | — | — |
| Financing Cash Flow | -$17.7M | — | — |
| Free Cash Flow | $91.7M | — | — |
| +178.8% |
| +19.5% |
| Net Income | $26.3M | +220.7% | — |
| EPS (Basic) | $0.35 | +218.2% | — |
| EPS (Diluted) | $0.34 | +209.1% | — |
| $90.4M |
| +5.1% |
| +13.0% |
| Stockholders' Equity | $402.4M | +3.2% | +24.8% |